TIGIT is highly expressed on tumor-infiltrating lymphocytes (TIL) in several hematological malignancies including follicular lymphoma, CLL, classic HL, AML, and relapsed MM, helping in tumor progression and poor outcome [137]. The gene discussed is TIGIT; the disease is B-cell chronic lymphocytic leukemia.